Recent studies have highlighted the lack of consensus among surgeons on the value of routine follow-up after apparently curative resection for colorectal cancer (Foster et al, 1987; Mella et al 1997) . In theory, the aim of regular follow-up is to detect and treat recurrence at an early stage in an attempt to improve survival. Most studies have focused on the early detection of local recurrence amenable to surgery (Schiessel et al, 1986; Pollard et al, 1989; Camunas et al, 1991) ; however, there is increasing evidence that this approach is both ineffective and costly (Bruinvels et al, 1994; Biggs and Ballantyne, 1994; Virgo et al, 1995) .
RESULTS
One hundred and fifty-seven patients were included in the study. Sixty-eight (43%) were women and the mean age at diagnosis was 61 years. One hundred and two patients had colonic and 55 had rectal cancers; of these, six (4%) patients had Dukes' stage A tumours, 94 (60%) had Dukes' stage B and 57 (36%) had Dukes' stage C tumours.
The mean patient follow-up is 45 months. None of the patients with Dukes A tumours have recurred. To date, 18 (19%) patients with Dukes B tumours and 32 (56%) with Dukes C tumours have developed recurrent disease.
Fourteen (9%) patients developed local recurrence, a further eight (5%) developed local recurrence in conjunction with metastatic disease and 28 (56%) developed disseminated disease without evidence of local recurrence. Of the 36 patients with disseminated disease, the first site affected was the liver in 24 and the lungs in a further four. The remaining eight patients recurred at multiple sites. The majority (72%) of all recurrences were detected within 30 months of primary surgery.
Of the 22 patients (ten rectal, 12 colonic) who developed local recurrence, eight (36%) were asymptomatic at the time of detection. In contrast, of the 24 patients who developed histologically proven liver metastases as the initial site of recurrence, 21 (87%) were asymptomatic at the time of detection (Figure 1) patients had metastases diagnosed initially by both ultrasound and CT scan and the remaining nine by CT alone. Two patients underwent hepatic resection for limited metastatic disease. Nineteen patients received chemotherapy; in nine of these, it was delivered by intra-arterial infusion. Patients with liver metastases detected at an asymptomatic stage had a median survival of 16 months (range 7-41 months) from the time of diagnosis, but survival in the group of patients with symptomatic metastases was less than 4 months.
DISCUSSION
It has been traditional for surgeons to review their patients at regular intervals after potentially curative resection. It is, however, still not clear whether follow-up is of benefit. Enthusiasts believe that intensive follow-up and early intervention will lead to a reduction in the number of deaths from colorectal cancer (Sugarbaker et al, 1987; Safi and Beyer, 1993) , whereas others point to the fact that the value of follow-up remains unproven (Cochrane et al, 1980; Ballantyne and Modlin, 1988) . Until recently, there were no randomized clinical trials, the best information being that from the meta-analysis performed by the Dutch group (Bruinvels et al, 1994) . In that analysis, the results of seven non-randomized studies comparing routine and intensive follow-up, designed to detect local recurrence, in over 3000 patients were evaluated. More asymptomatic recurrences were detected and resected in the intensive follow-up group. However, there was no significant difference in survival. When the analysis was restricted to those studies that included carcinoembryonic antigen (CEA) measurements, there was an apparent 9% increase in 5-year survival in the intensively investigated group. The authors interpreted this data cautiously, recognizing that a number of biases were present.
Recently, three randomized trials comparing minimal with intensive follow-up have been reported (Makela et al, 1995; Ohlsson et al, 1995; Kjeldsen et al, 1997) . In the largest of these studies, 600 patients were randomized to either 6 monthly followup or to follow-up visits at 5 and 10 years (Kjeldsen et al, 1997) . Investigations consisted of history and clinical examination, full blood count and liver enzymes, faecal occult blood, chest radiograph and colonoscopy. No routine liver imaging was performed. Recurrence rates were similar in both groups but the tumour recurrences in the intensive group were detected on average 9 months earlier, often at an asymptomatic stage. Subsequently, more of these patients underwent reoperation with curative intent. There was, however, no difference in overall or cancer-related survival between the two groups. The authors concluded that an intensive follow-up plan is not justified considering the small proportion of patients reoperated on for cure and the fact that no survival advantage was detected.
An alternative approach has been evaluated by Northover et al (1994) . Patients undergoing potentially curative surgery were randomized to an active intervention group or a control group. CEA was measured in all patients at frequent intervals. In the active intervention group, a rising CEA prompted further investigation, including second-look laparotomy if appropriate. Preliminary analysis has shown no difference in survival between the two groups.
It may be that the above studies were based on a false premise, namely that intensive follow-up would identify local recurrence at a stage when it would be amenable to further potentially curative surgery. However, the results of the above studies have shown that although intensive follow-up detects more local recurrences at an asymptomatic stage resulting in more reoperations, there is no difference in overall or disease-related survival.
Follow-up designed to detect asymptomatic liver metastases may be more effective. In our study, 21 of the 24 patients who developed liver metastases were detected at an asymptomatic stage; two underwent liver resection and 19 received chemotherapy. It has been estimated that 600 patients per year in the UK would be suitable for resection (Allen-Mersh, 1989) ; however, the number of resections performed is considerably less. It is worth noting that in the contemporary studies of liver resection, mortality is usually less than 5% and approximately 35% of patients survive 5 years (Ballantye, 1993) . These survival figures are comparable or better than the results obtained after primary surgery for many types of gastrointestinal surgery. Furthermore, recent studies have shown that patients with disseminated disease receiving systemic chemotherapy at an asymptomatic stage had higher response rates, better quality of life and improved survival compared with those patients in whom the administration of chemotherapy was delayed until the patients became symptomatic (Nordic Gastrointestinal Tumor Adjuvant Therapy Group, 1992) . Therefore, if liver metastases were diagnosed in more patients at a point when they would be amenable to treatment, either resection or chemotherapy, more long-term survivors might be anticipated.
Perhaps the time has come to readdress the question of followup. In addition to those investigations designed to detect locoregional recurrence, future studies should include intensive liver imaging during the first 3 years, with a view to identifying patients suitable for either resection of liver secondaries or chemotherapy. Further randomized trials comparing intensive with minimal follow-up are currently being discussed at national and international level.
